Page 5 - Ying Zhao News Today : Breaking News, Live Updates & Top Stories | Vimarsana

JW Therapeutics Announces Initiation of Clinical Study of Carteyva® in First-line Treatment in Patients with High-Risk Large B-Cell Lymphoma

/PRNewswire/ JW Therapeutics (HKEX: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing.

United kingdomYing zhaoA bristol myers squibbNational significant new drug development programInternational prognostic indexIntergroup trial allianceChina national medical products administrationChina association lymphoma committeeAnti cancer association lymphoma committeeChinj oncolRelmacabtagene autoleucel injectionJuno therapeuticsBristol myers squibbJw therapeuticsHealth care amp hospitalsMedical pharmaceuticals

JW Therapeutics Announces Initiation of Clinical Study of Carteyva® in First-line Treatment in Patients with High-Risk Large B-Cell Lymphoma

JW Therapeutics Announces Initiation of Clinical Study of Carteyva® in First-line Treatment in Patients with High-Risk Large B-Cell Lymphoma
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Hong kongUnited kingdomYing zhaoA bristol myers squibbNational significant new drug development programInternational prognostic indexIntergroup trial allianceChina national medical products administrationClearing limitedChina association lymphoma committeeAnti cancer association lymphoma committeeChinj oncolRelmacabtagene autoleucel injectionJuno therapeuticsBristol myers squibbHong kong exchanges

JW Therapeutics Announces Initiation of Clinical Study of Carteyva® in First-line Treatment in Patients with High-Risk Large B-Cell Lymphoma

SHANGHAI, March 8, 2023 /PRNewswire/ JW Therapeutics (HKEX: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunotherapy products, announced the initiation of clinical study of Carteyva® (relmacabtagene autoleucel injection) for first-line treatment in patients with high-risk large B-cell lymphoma and the first patient infusion. High-risk large B-cell lymphoma includes large B-cell lymphoma.

United kingdomYing zhaoA bristol myers squibbNational significant new drug development programInternational prognostic indexIntergroup trial allianceChina national medical products administrationChina association lymphoma committeeAnti cancer association lymphoma committeeChinj oncolRelmacabtagene autoleucel injectionJuno therapeuticsBristol myers squibb

Immunotherapy Could Treat Ovarian Cancer: Study

Immunotherapy Could Treat Ovarian Cancer: Study
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Moustapha hassanIsabelle magalhaesKarolinska institutetJonas mattssonEsther schoutropJohan henrikssonYing zhaoIbrahim el serafiSwedish research councilSwedish cancer societyCancer research funds of radiumhemmetSwedish childhood cancer foundationDepartment of oncologyCancer research fundsThomas poiretAlina moter

New immunotherapy holds promise for ovarian cancer

New immunotherapy holds promise for ovarian cancer
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Moustapha hassanIsabelle magalhaesKarolinska institutetHelen kaipeJonas mattssonEsther schoutropJohan henrikssonYing zhaoIbrahim el serafiSwedish research councilSwedish cancer societyCancer research funds of radiumhemmetSwedish childhood cancer foundationDepartment of oncologyCancer research fundsThomas poiret